Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.49 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including other brain neurons; strongest in retinal horizontal cells | 0.75 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 12 Parkinson's papers of 464 | 0.66 |
| pathways Reactome | 2 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 0249
Sealed predictions
- KIF1A in dopamine neurons, braak-0.56 (p 0.118) → -0.82 (p 0.007)receipt 0255
Swarm cases
receipt 0255: KIF1A in dopamine neurons, braak
- power
- full sample -0.63 (p 0.0049, n 18), 95% CI -0.85 to -0.23. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.58 (p 0.011, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.64 (p 0.0039, n 18). not the mix.
- skeptic
- leave-one-out range -0.77 to -0.59, sign flips 0; without severely affected donors -0.63 (p 0.0049, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KIF1A in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts